
Global mRNA Vaccines & Therapeutics Market Analysis and Forecast 2025-2031
Description
Summary
According to APO Research, The global mRNA Vaccines & Therapeutics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of mRNA Vaccines & Therapeutics include Translate Bio, Tiba Biotechnology, Sangamo Therapeutics, Moderna Therapeutics, In-Cell-Art, Ethris, eTheRNA, CureVac and BioNTech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for mRNA Vaccines & Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of mRNA Vaccines & Therapeutics, also provides the sales of main regions and countries. Of the upcoming market potential for mRNA Vaccines & Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the mRNA Vaccines & Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global mRNA Vaccines & Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for mRNA Vaccines & Therapeutics sales, projected growth trends, production technology, application and end-user industry.
mRNA Vaccines & Therapeutics Segment by Company
Translate Bio
Tiba Biotechnology
Sangamo Therapeutics
Moderna Therapeutics
In-Cell-Art
Ethris
eTheRNA
CureVac
BioNTech
Argos Therapeutics
mRNA Vaccines & Therapeutics Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
mRNA Vaccines & Therapeutics Segment by Application
Infectious Disease
Cancer
mRNA Vaccines & Therapeutics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Vaccines & Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of mRNA Vaccines & Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Vaccines & Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of mRNA Vaccines & Therapeutics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Vaccines & Therapeutics sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
According to APO Research, The global mRNA Vaccines & Therapeutics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of mRNA Vaccines & Therapeutics include Translate Bio, Tiba Biotechnology, Sangamo Therapeutics, Moderna Therapeutics, In-Cell-Art, Ethris, eTheRNA, CureVac and BioNTech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for mRNA Vaccines & Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of mRNA Vaccines & Therapeutics, also provides the sales of main regions and countries. Of the upcoming market potential for mRNA Vaccines & Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the mRNA Vaccines & Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global mRNA Vaccines & Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for mRNA Vaccines & Therapeutics sales, projected growth trends, production technology, application and end-user industry.
mRNA Vaccines & Therapeutics Segment by Company
Translate Bio
Tiba Biotechnology
Sangamo Therapeutics
Moderna Therapeutics
In-Cell-Art
Ethris
eTheRNA
CureVac
BioNTech
Argos Therapeutics
mRNA Vaccines & Therapeutics Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
mRNA Vaccines & Therapeutics Segment by Application
Infectious Disease
Cancer
mRNA Vaccines & Therapeutics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Vaccines & Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of mRNA Vaccines & Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Vaccines & Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of mRNA Vaccines & Therapeutics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Vaccines & Therapeutics sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Table of Contents
199 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 mRNA Vaccines & Therapeutics Market by Type
- 1.2.1 Global mRNA Vaccines & Therapeutics Market Size by Type, 2020 VS 2024 VS 2031
- 1.2.2 Infectious Disease Vaccines
- 1.2.3 Cancer Vaccines
- 1.3 mRNA Vaccines & Therapeutics Market by Application
- 1.3.1 Global mRNA Vaccines & Therapeutics Market Size by Application, 2020 VS 2024 VS 2031
- 1.3.2 Infectious Disease
- 1.3.3 Cancer
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 mRNA Vaccines & Therapeutics Market Dynamics
- 2.1 mRNA Vaccines & Therapeutics Industry Trends
- 2.2 mRNA Vaccines & Therapeutics Industry Drivers
- 2.3 mRNA Vaccines & Therapeutics Industry Opportunities and Challenges
- 2.4 mRNA Vaccines & Therapeutics Industry Restraints
- 3 Global Market Growth Prospects
- 3.1 Global mRNA Vaccines & Therapeutics Revenue Estimates and Forecasts (2020-2031)
- 3.2 Global mRNA Vaccines & Therapeutics Revenue by Region
- 3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Region: 2020 VS 2024 VS 2031
- 3.2.2 Global mRNA Vaccines & Therapeutics Revenue by Region (2020-2025)
- 3.2.3 Global mRNA Vaccines & Therapeutics Revenue by Region (2026-2031)
- 3.2.4 Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2020-2031)
- 3.3 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts 2020-2031
- 3.4 Global mRNA Vaccines & Therapeutics Sales by Region
- 3.4.1 Global mRNA Vaccines & Therapeutics Sales by Region: 2020 VS 2024 VS 2031
- 3.4.2 Global mRNA Vaccines & Therapeutics Sales by Region (2020-2025)
- 3.4.3 Global mRNA Vaccines & Therapeutics Sales by Region (2026-2031)
- 3.4.4 Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2020-2031)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
- 4 Market Competitive Landscape by Manufacturers
- 4.1 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers
- 4.1.1 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers (2020-2025)
- 4.1.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2020-2025)
- 4.1.3 Global mRNA Vaccines & Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2024
- 4.2 Global mRNA Vaccines & Therapeutics Sales by Manufacturers
- 4.2.1 Global mRNA Vaccines & Therapeutics Sales by Manufacturers (2020-2025)
- 4.2.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2020-2025)
- 4.2.3 Global mRNA Vaccines & Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2024
- 4.3 Global mRNA Vaccines & Therapeutics Sales Price by Manufacturers (2020-2025)
- 4.4 Global mRNA Vaccines & Therapeutics Key Manufacturers Ranking, 2023 VS 2024 VS 2025
- 4.5 Global mRNA Vaccines & Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global mRNA Vaccines & Therapeutics Manufacturers, Product Type & Application
- 4.7 Global mRNA Vaccines & Therapeutics Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global mRNA Vaccines & Therapeutics Market CR5 and HHI
- 4.8.2 2024 mRNA Vaccines & Therapeutics Tier 1, Tier 2, and Tier 3
- 5 mRNA Vaccines & Therapeutics Market by Type
- 5.1 Global mRNA Vaccines & Therapeutics Revenue by Type
- 5.1.1 Global mRNA Vaccines & Therapeutics Revenue by Type (2020 VS 2024 VS 2031)
- 5.1.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2020-2031) & (US$ Million)
- 5.1.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2020-2031)
- 5.2 Global mRNA Vaccines & Therapeutics Sales by Type
- 5.2.1 Global mRNA Vaccines & Therapeutics Sales by Type (2020 VS 2024 VS 2031)
- 5.2.2 Global mRNA Vaccines & Therapeutics Sales by Type (2020-2031) & (M Units)
- 5.2.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2031)
- 5.3 Global mRNA Vaccines & Therapeutics Price by Type
- 6 mRNA Vaccines & Therapeutics Market by Application
- 6.1 Global mRNA Vaccines & Therapeutics Revenue by Application
- 6.1.1 Global mRNA Vaccines & Therapeutics Revenue by Application (2020 VS 2024 VS 2031)
- 6.1.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2020-2031) & (US$ Million)
- 6.1.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2020-2031)
- 6.2 Global mRNA Vaccines & Therapeutics Sales by Application
- 6.2.1 Global mRNA Vaccines & Therapeutics Sales by Application (2020 VS 2024 VS 2031)
- 6.2.2 Global mRNA Vaccines & Therapeutics Sales by Application (2020-2031) & (M Units)
- 6.2.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2031)
- 6.3 Global mRNA Vaccines & Therapeutics Price by Application
- 7 Company Profiles
- 7.1 Translate Bio
- 7.1.1 Translate Bio Comapny Information
- 7.1.2 Translate Bio Business Overview
- 7.1.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
- 7.1.5 Translate Bio Recent Developments
- 7.2 Tiba Biotechnology
- 7.2.1 Tiba Biotechnology Comapny Information
- 7.2.2 Tiba Biotechnology Business Overview
- 7.2.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
- 7.2.5 Tiba Biotechnology Recent Developments
- 7.3 Sangamo Therapeutics
- 7.3.1 Sangamo Therapeutics Comapny Information
- 7.3.2 Sangamo Therapeutics Business Overview
- 7.3.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
- 7.3.5 Sangamo Therapeutics Recent Developments
- 7.4 Moderna Therapeutics
- 7.4.1 Moderna Therapeutics Comapny Information
- 7.4.2 Moderna Therapeutics Business Overview
- 7.4.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
- 7.4.5 Moderna Therapeutics Recent Developments
- 7.5 In-Cell-Art
- 7.5.1 In-Cell-Art Comapny Information
- 7.5.2 In-Cell-Art Business Overview
- 7.5.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
- 7.5.5 In-Cell-Art Recent Developments
- 7.6 Ethris
- 7.6.1 Ethris Comapny Information
- 7.6.2 Ethris Business Overview
- 7.6.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Ethris mRNA Vaccines & Therapeutics Product Portfolio
- 7.6.5 Ethris Recent Developments
- 7.7 eTheRNA
- 7.7.1 eTheRNA Comapny Information
- 7.7.2 eTheRNA Business Overview
- 7.7.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
- 7.7.5 eTheRNA Recent Developments
- 7.8 CureVac
- 7.8.1 CureVac Comapny Information
- 7.8.2 CureVac Business Overview
- 7.8.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 CureVac mRNA Vaccines & Therapeutics Product Portfolio
- 7.8.5 CureVac Recent Developments
- 7.9 BioNTech
- 7.9.1 BioNTech Comapny Information
- 7.9.2 BioNTech Business Overview
- 7.9.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.9.4 BioNTech mRNA Vaccines & Therapeutics Product Portfolio
- 7.9.5 BioNTech Recent Developments
- 7.10 Argos Therapeutics
- 7.10.1 Argos Therapeutics Comapny Information
- 7.10.2 Argos Therapeutics Business Overview
- 7.10.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.10.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
- 7.10.5 Argos Therapeutics Recent Developments
- 8 North America
- 8.1 North America mRNA Vaccines & Therapeutics Market Size by Type
- 8.1.1 North America mRNA Vaccines & Therapeutics Revenue by Type (2020-2031)
- 8.1.2 North America mRNA Vaccines & Therapeutics Sales by Type (2020-2031)
- 8.1.3 North America mRNA Vaccines & Therapeutics Price by Type (2020-2031)
- 8.2 North America mRNA Vaccines & Therapeutics Market Size by Application
- 8.2.1 North America mRNA Vaccines & Therapeutics Revenue by Application (2020-2031)
- 8.2.2 North America mRNA Vaccines & Therapeutics Sales by Application (2020-2031)
- 8.2.3 North America mRNA Vaccines & Therapeutics Price by Application (2020-2031)
- 8.3 North America mRNA Vaccines & Therapeutics Market Size by Country
- 8.3.1 North America mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 8.3.2 North America mRNA Vaccines & Therapeutics Sales by Country (2020 VS 2024 VS 2031)
- 8.3.3 North America mRNA Vaccines & Therapeutics Price by Country (2020-2031)
- 8.3.4 United States
- 8.3.5 Canada
- 9 Europe
- 9.1 Europe mRNA Vaccines & Therapeutics Market Size by Type
- 9.1.1 Europe mRNA Vaccines & Therapeutics Revenue by Type (2020-2031)
- 9.1.2 Europe mRNA Vaccines & Therapeutics Sales by Type (2020-2031)
- 9.1.3 Europe mRNA Vaccines & Therapeutics Price by Type (2020-2031)
- 9.2 Europe mRNA Vaccines & Therapeutics Market Size by Application
- 9.2.1 Europe mRNA Vaccines & Therapeutics Revenue by Application (2020-2031)
- 9.2.2 Europe mRNA Vaccines & Therapeutics Sales by Application (2020-2031)
- 9.2.3 Europe mRNA Vaccines & Therapeutics Price by Application (2020-2031)
- 9.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
- 9.3.1 Europe mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 9.3.2 Europe mRNA Vaccines & Therapeutics Sales by Country (2020 VS 2024 VS 2031)
- 9.3.3 Europe mRNA Vaccines & Therapeutics Price by Country (2020-2031)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
- 10 China
- 10.1 China mRNA Vaccines & Therapeutics Market Size by Type
- 10.1.1 China mRNA Vaccines & Therapeutics Revenue by Type (2020-2031)
- 10.1.2 China mRNA Vaccines & Therapeutics Sales by Type (2020-2031)
- 10.1.3 China mRNA Vaccines & Therapeutics Price by Type (2020-2031)
- 10.2 China mRNA Vaccines & Therapeutics Market Size by Application
- 10.2.1 China mRNA Vaccines & Therapeutics Revenue by Application (2020-2031)
- 10.2.2 China mRNA Vaccines & Therapeutics Sales by Application (2020-2031)
- 10.2.3 China mRNA Vaccines & Therapeutics Price by Application (2020-2031)
- 11 Asia (Excluding China)
- 11.1 Asia mRNA Vaccines & Therapeutics Market Size by Type
- 11.1.1 Asia mRNA Vaccines & Therapeutics Revenue by Type (2020-2031)
- 11.1.2 Asia mRNA Vaccines & Therapeutics Sales by Type (2020-2031)
- 11.1.3 Asia mRNA Vaccines & Therapeutics Price by Type (2020-2031)
- 11.2 Asia mRNA Vaccines & Therapeutics Market Size by Application
- 11.2.1 Asia mRNA Vaccines & Therapeutics Revenue by Application (2020-2031)
- 11.2.2 Asia mRNA Vaccines & Therapeutics Sales by Application (2020-2031)
- 11.2.3 Asia mRNA Vaccines & Therapeutics Price by Application (2020-2031)
- 11.3 Asia mRNA Vaccines & Therapeutics Market Size by Country
- 11.3.1 Asia mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 11.3.2 Asia mRNA Vaccines & Therapeutics Sales by Country (2020 VS 2024 VS 2031)
- 11.3.3 Asia mRNA Vaccines & Therapeutics Price by Country (2020-2031)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
- 12 South America, Middle East and Africa
- 12.1 SAMEA mRNA Vaccines & Therapeutics Market Size by Type
- 12.1.1 SAMEA mRNA Vaccines & Therapeutics Revenue by Type (2020-2031)
- 12.1.2 SAMEA mRNA Vaccines & Therapeutics Sales by Type (2020-2031)
- 12.1.3 SAMEA mRNA Vaccines & Therapeutics Price by Type (2020-2031)
- 12.2 SAMEA mRNA Vaccines & Therapeutics Market Size by Application
- 12.2.1 SAMEA mRNA Vaccines & Therapeutics Revenue by Application (2020-2031)
- 12.2.2 SAMEA mRNA Vaccines & Therapeutics Sales by Application (2020-2031)
- 12.2.3 SAMEA mRNA Vaccines & Therapeutics Price by Application (2020-2031)
- 12.3 SAMEA mRNA Vaccines & Therapeutics Market Size by Country
- 12.3.1 SAMEA mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 12.3.2 SAMEA mRNA Vaccines & Therapeutics Sales by Country (2020 VS 2024 VS 2031)
- 12.3.3 SAMEA mRNA Vaccines & Therapeutics Price by Country (2020-2031)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
- 13 Value Chain and Sales Channels Analysis
- 13.1 mRNA Vaccines & Therapeutics Value Chain Analysis
- 13.1.1 mRNA Vaccines & Therapeutics Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 mRNA Vaccines & Therapeutics Production Mode & Process
- 13.2 mRNA Vaccines & Therapeutics Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 mRNA Vaccines & Therapeutics Distributors
- 13.2.3 mRNA Vaccines & Therapeutics Customers
- 14 Concluding Insights
- 15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.